Stroke Alliance for Europe
(the Stroke patient voice in Europe)
(the Stroke patient voice in Europe)
Europe is failing to provide adequate stroke care and support The scale of stroke care crisis is laid bare by new data release New data collected as part of the Stroke Action Plan for Europe (SAP-E)...
On April 14, the ESO published their 4th information letter about alteplase and tenecteplase shortage in Europe.
Thrombolytic drug shortage is expected to last until 2024. The manufacturing company is limiting supply to all countries worldwide. Currently, the impact on future drug delivery is still unclear....